How and When to Implement Precision Oncology
MAY 25, 2017
Lincoln D. Nadauld, MD, PhD, and Derrick S. Haslem, MD
- Clinical implementation of precision cancer medicine and active treatment of patients with targeted therapies continue to be challenges for health care providers.
- Input from a molecular tumor board confers collective insight and experience on treatment decisions and may also provide confidence for physicians who have less experience with interpreting molecular testing results.
- Given the myriad genomic alterations and targeted-therapy combinations in precision oncology, innovative basket and umbrella trial designs, together with large meta-analyses and well-designed retrospective studies, are likely to provide the most clarity about clinical outcomes.